Bowel perforation after radiotherapy in a patient receiving sorafenib

J Clin Oncol. 2008 May 10;26(14):2405-6. doi: 10.1200/JCO.2007.15.8451.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents
  • Benzenesulfonates / adverse effects*
  • Benzenesulfonates / therapeutic use
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / radiotherapy
  • Carcinoma, Renal Cell / secondary
  • Carcinoma, Renal Cell / therapy*
  • Combined Modality Therapy
  • Female
  • Humans
  • Intestinal Perforation / chemically induced
  • Intestinal Perforation / etiology*
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / radiotherapy
  • Kidney Neoplasms / therapy*
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Radiation Injuries / etiology*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / radiotherapy
  • Skin Neoplasms / secondary
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib